These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 793267)

  • 1. Further observations on the therapy with a beta-stimulating agent in Raynaud's phenomenon.
    Thune P; Fyrand O
    Acta Chir Scand Suppl; 1976; 465():84-6. PubMed ID: 793267
    [No Abstract]   [Full Text] [Related]  

  • 2. Plethysmographical and clinical observations on Bricanyl therapy in Raynaud's phenomenon.
    Zabel J; Fyrand O; Thune P
    Acta Derm Venereol; 1974; 54(5):391-5. PubMed ID: 4138501
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical treatment in Raynaud's disease.
    Hansteen V
    Acta Chir Scand Suppl; 1976; 465():87-91. PubMed ID: 793268
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validity of plethysmography and the digital temperature recovery test in the diagnosis of primary and occupational Raynaud's phenomenon].
    Laroche GP; Thériault G
    Clin Invest Med; 1987 Mar; 10(2):96-102. PubMed ID: 3581549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does serotonin receptor blockade have a therapeutic effect in Raynaud's phenomenon?
    Brouwer RM; Wenting GJ; Visser W; Schalekamp MA
    Vasa Suppl; 1987; 18():64-7. PubMed ID: 3299817
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy of Raynaud's phenomenon (author's transl)].
    Goebel KM; Neitzert A
    Ther Umsch; 1975 Jun; 32(6):350-6. PubMed ID: 806127
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of raynaud's disease and phenomenon with intraarterial reserpine (author's transl)].
    González Folch M; Saffie F
    Rev Med Chil; 1976 Jan; 104(1):21-4. PubMed ID: 788084
    [No Abstract]   [Full Text] [Related]  

  • 10. Methods of evaluating Raynaud's phenomenon for the purpose of pharmacotherapeutic research.
    Wouda AA
    Vasa Suppl; 1987; 18():32-9. PubMed ID: 3474798
    [No Abstract]   [Full Text] [Related]  

  • 11. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
    Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
    J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB; Guseva NG; Mach ES
    Ter Arkh; 1987; 59(4):89-92. PubMed ID: 3296288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon.
    Holti G
    Practitioner; 1982 Apr; 226(1366):781-3. PubMed ID: 7045853
    [No Abstract]   [Full Text] [Related]  

  • 14. Skin temperature changes in Raynaud's disease after griseofulvin.
    Charles CR; Carmick ES
    Arch Dermatol; 1970 Mar; 101(3):331-6. PubMed ID: 5414890
    [No Abstract]   [Full Text] [Related]  

  • 15. Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon.
    Wesseling H; den Heeten A; Wouda AA
    Eur J Clin Pharmacol; 1981; 20(5):329-33. PubMed ID: 7026260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A; Amor B; Menkès CJ
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists].
    Shcherbakov AB
    Vutr Boles; 1988; 27(6):55-8. PubMed ID: 3247706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
    Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
    Vasa Suppl; 1987; 18():68-70. PubMed ID: 3299818
    [No Abstract]   [Full Text] [Related]  

  • 19. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Rhedda A; McCans J; Willan AR; Ford PM
    J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.